Geode Capital Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Geode Capital Management’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-403,529	Closed	-$10.9M	–	4876
2022 Q4	$10.9M	Buy	403,529 +8,073	+2%	+$212K	﹤0.01%	2213
2022 Q3	$7.1M	Sell	395,456 -23,064	-6%	-$368K	﹤0.01%	2474
2022 Q2	$5.2M	Buy	418,520 +26,686	+7%	+$294K	﹤0.01%	2679
2022 Q1	$5.22M	Buy	391,834 +21,228	+6%	+$285K	﹤0.01%	2775
2021 Q4	$5.77M	Buy	370,606 +8,800	+2%	+$168K	﹤0.01%	2818
2021 Q3	$8.12M	Buy	361,806 +16,983	+5%	+$373K	﹤0.01%	2619
2021 Q2	$7.85M	Buy	344,823 +12,104	+4%	+$255K	﹤0.01%	2629
2021 Q1	$6.85M	Buy	+332,719	New	+$7.57M	﹤0.01%	2622
2017 Q2	–	Sell	-18,645	Closed	-$218K	–	4124
2017 Q1	$218K	Buy	18,645 +2,288	+14%	+$26.2K	﹤0.01%	3626
2016 Q4	$203K	Buy	+16,357	New	+$190K	﹤0.01%	3621

Other funds holding MYOV

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Geode Capital Management's MYOV Position: Q1 2023 in Review

Geode Capital Management sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 403,529 shares — an estimated $10.9M sold.

Geode Capital Management first reported a position in MYOV in Q4 2016 and held it in 10 quarters. The position peaked at $10.9M in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

Geode Capital Management reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
Geode Capital Management sold 403,529 Myovant Sciences Ltd. shares in Q1 2023, an estimated $10.9M.
Geode Capital Management first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 10 quarters.
Geode Capital Management's Myovant Sciences Ltd. position peaked at $10.9M in Q4 2022.
2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.